Extended-release buprenorphine is a highly effective treatment for opioid use disorder that reduces staffing expenses and diversion risk. It enables individuals to receive OUD treatment for up to 28 days post-release, reducing the risk of drug overdose and recidivism. In this discussion, hear about the lessons learned as a rural Maine jail developed and implemented an XRB treatment program for individuals with OUD. Presenters will discuss the importance of enhancing staff buy-in, medication administration protocols, and how to enhance collaboration with community partners.

Educational Objectives

• Describe the licensing and educational requirements of XRB program implementation
• Review best practices in screening and treating incarcerated individuals with OUD
• Discuss strategies for connecting patients with community treatment partners after release

Level: Basic